Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark

Renal Dysfunction, Stroke Risk Scores (CHADS 2 , CHA 2 DS 2 -VASc, and R 2 CHADS 2 ), and the Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation

(2013) Jelena Kornej et al.   Circulation-Arrhythmia and Electrophysiology

Temporal changes in patient characteristics and prior pharmacotherapy in patients undergoing radiofrequency ablation of atrial fibrillation: a Danish nationwide cohort study

(2013) Deniz Karasoy et al.   EUROPACE

Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes

(2013) Roger A. Winkle et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation—The potential role beyond the CHA2DS2-VASc score

(2012) Tze-Fan Chao et al.   HEART RHYTHM

Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding

(2012) Charlotte Mérie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Very Low Risk of Thromboembolic Events in Patients Undergoing Successful Catheter Ablation of Atrial Fibrillation With a CHADS 2 Score ≤3

(2011) Eduardo B. Saad et al.   Circulation-Arrhythmia and Electrophysiology

Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors

(2011) Hana Hoyt et al.   HEART RHYTHM

CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation

(2011) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

(2011) J. B. OLESEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

An automated database case definition for serious bleeding related to oral anticoagulant use

(2011) Andrew Cunningham et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2010) Luigi Di Biase et al.   CIRCULATION

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation

(2010) Sakis Themistoclakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Incidence and Predictors of Periprocedural Cerebrovascular Accident in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2009) DANIEL SCHERR et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Warfarin Is Not Needed in Low-Risk Patients Following Atrial Fibrillation Ablation Procedures

(2009) T. JARED BUNCH et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Late thromboembolic events after circumferential pulmonary vein ablation of atrial fibrillation

(2009) Hailong Tao et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET

Accuracy of a heart failure diagnosis in administrative registers

(2008) Thomas Kümler et al.   EUROPEAN JOURNAL OF HEART FAILURE

Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry

(2008) Albert Marni Joensen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation

(2008) Koonlawee Nademanee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY